相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 询价记录
- 文献和实验
- 技术资料
- 保存条件:
Powder: -20°C, 3 years; 4°C, 2 years.In solvent: -80°C, 6 months; -20°C, 1 month.
- 库存:
货期:1-2天
- 供应商:
MedChemExpress LLC
- CAS号:
1345808-25-4
- 规格:
10 mM * 1 mL/2 mg/5 mg/10 mg
| 规格: | 10 mM * 1 mL | 产品价格: | ¥2518.0 |
|---|---|---|---|
| 规格: | 2 mg | 产品价格: | ¥1600.0 |
| 规格: | 5 mg | 产品价格: | ¥2400.0 |
| 规格: | 10 mg | 产品价格: | ¥4200.0 |
MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。
Arginase inhibitor 1
CAS No. : 1345808-25-4
MCE 国际站:Arginase inhibitor 1
产品活性:Arginase inhibitor 1 是一种有效的人精氨酸酶 (arginases I 和 II)抑制剂,IC50 分别为 223 和 509 nM。
研究领域:Immunology/Inflammation | Metabolic Enzyme/Protease
作用靶点:Arginase
In Vitro: Arginase inhibitor 1inhibits human arginases I and II with IC50s of 223±22.3 and 509±85.1 nM, respectively, and is active in a recombinant cellular assay overexpressing human arginase I (CHO cells). Arginase inhibitor 1 is a novel second generation arginase inhibitor with significant activity in a rat model of myocardial ischemia/reperfusion injury (MI/RI). Arginase inhibitor 1 is potent against hARG I in both in vitro enzyme and cellular assays. The IC50 for Arginase inhibitor 1 is 8 μM in CHO Cells Over-Expressing hArgI.
In Vivo: Following i.v. dosing with 10 mg/kg in fasted animals, Arginase inhibitor 1has a terminal elimination half-life (t1/2) of 3.3 h with a volume of distribution and total body clearance of 1.86 L/kg and 7.89 mL/min/kg, respectively. The oral bioavailability of Arginase inhibitor 1 (10 mg/kg, p.o.) is 28% with a Cmax of 0.45 mg/L.
相关产品:Covalent Screening Library Plus | Bioactive Compound Library Plus | Immunology/Inflammation Compound Library | Metabolism/Protease Compound Library | Anti-Cancer Compound Library | Small Molecule Immuno-Oncology Compound Library | Covalent Screening Library | Anti-Cancer Metabolism Compound Library | Targeted Diversity Library | nor-NOHA monoacetate | Numidargistat dihydrochloride | BEC hydrochloride | 2-Aminoimidazole | Broussonin E | Piceatannol 3'-O-glucoside | DL-Norvaline | ABH hydrochloride | ARG1-IN-1 | Lacto-N-fucopentaose III | OATD-02
热门产品线:重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Dye Reagents | PROTAC | Isotope-Labeled Compounds
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
- 作者
- 内容
- 询问日期
文献和实验The 25A/RNase L Pathway and Inhibition by RNase L Inhibitor (RLI)
Interferons (IFN) belong to a multigenic family of cytokines that activate the transcription of several genes through a signaling pathway involving cell-surface receptors (IFNAR), Janus kinases (JAK), and signal-transducing proteins (STAT
of diverse origin. The protease inhibitors that have been isolated from soybeans and other legumes fall biochemically into two main categories: (1) those that have a molecular weight of 20,000 to 25,000 Da with relatively few disulfi de bonds and a specifi
lyc_urology 本人,研一,要转染miRNA inhibitor,请教前辈: 1、转染细胞一般inhibitor多少浓度?50nM?25nM? 2、而且本人转然后,需要做MTT,WESTERN等实验,这需要考虑转染效率吗?怎么来判断转染效率呢? 3、顺便问一下,抑制miRNA,就买个inhibitor和阴性对照就行了吧?还需要用阳性对照吗? 4、转然后分别多久做MTT、Western、克隆形成实验以及流失细胞仪测
技术资料暂无技术资料 索取技术资料

















